Story perspectives

CDC Considers Single-Dose HPV Vaccine Amid Controversy

1/8/2026

43 7

Summary

Story summary

An independent vaccine advisory group will review the U.S. recommendation for a single-dose HPV vaccine, diverging from FDA-approved two- or three-dose regimens.
The CDC's change, influenced by Health and Human Services Secretary Robert F. Kennedy Jr. and U.S. President Donald Trump, bypassed the review process.
Merck, which manufactures Gardasil, warns that a single-dose regimen may be less effective.
The Vaccine Integrity Project is examining this and other vaccine recommendations.

1 of 1

Story summary

An independent vaccine advisory group will review the U.S. recommendation for a single-dose HPV vaccine, diverging from FDA-approved two- or three-dose regimens.
The CDC's change, influenced by Health and Human Services Secretary Robert F. Kennedy Jr. and U.S. President Donald Trump, bypassed the review process.
Merck, which manufactures Gardasil, warns that a single-dose regimen may be less effective.
The Vaccine Integrity Project is examining this and other vaccine recommendations.